2021 Call - Now Live!
MRC CiC/Leicester Drug Discovery and Diagnostics (LD3) 2021 Call
Accelerating translational research at the University of Leicester
We are looking to fund innovative, translational projects at various stages of development, from target validation/Proof of Concept studies to pre-clinical testing.
Priority areas should accelerate innovative translational research towards the development of novel medicines, therapies, devices, diagnostic tests and precision medicine approaches in Leicester.
Please note: MRC terms mean that this cannot be used for bridging salary funding between grants.
Award value: up to 70k.
Duration: projects should be up to 12 months and must finish by end of Nov 2022.
Closing date for application: Friday August 27th - 5pm.
Elevator pitch for top-ranked PIs and funding decision: TBC – Late September.
For more information about the award and application process, please contact: Dr Carl Edwards, LD3 Research Manager email@example.com.